首页> 外文期刊>生殖与避孕:英文版 >Comparative Study on the Effects of Two Contraceptive Injections (Mesigyna, Cyclofem) on Blood Coagulation and Fibrinolysis
【24h】

Comparative Study on the Effects of Two Contraceptive Injections (Mesigyna, Cyclofem) on Blood Coagulation and Fibrinolysis

机译:两种避孕药(Mesigyna,Cyclofem)对凝血和纤溶作用影响的比较研究

摘要

The effects of consecutively using the contraceptive injections (Mesigyna or Cy-clofem) on both blood coagulation and fibrinolysis were evaluated on 94 Chinese women who had been injected with one of these two injections once a month for 9 months. To provide the evidences on the safety of long-term use, relevant parame-ters were observed before the treatment, after the injection 3 and 9, as well as 3 months after drug withdrawing. The results were as follows: Among those who had been injected with Mesigyna, the levels of factor Ⅶ and factor Ⅹ declined signifi-cantly during treatment. The activity of AT- Ⅲ , plasminogen and the concentration of protein C also decreased. Moreover, the corresponding parameters did not recov-ered to the normal level after stopping treatment. Prothrombin time (PT) and acti-vated partial thromboplastin time (APTT) were prolonged in the early period of treatment, but recovered to the normal at week 47 (injection withdrawn).No or slight change was observed in other parameters. Among the woman injected with Cy-clofem, the concentrations of factor Ⅶ and plasminogen decreased over time, while the tissue plasminogen activator inhibitor (t-PAI) levels increased after the 9th injec-tion and recovered to normal at week 47 after discontinuation of treatment. The re-suits suggested that some significant parameter changes of coagulation and of fibri-nolysis could be detected among long-term users, but their impact on the fibrinolysis system was not obvious. The observed phenomenon did not show a tendency to facili-tate thromboembolism and possibility of being harmful to the users. Thus, the ob-served changes should be regarded as the reactions to keep the equilibrium between coagulation and fibrinolysis and had no marked clinical pathological significance on the users.
机译:连续连续9个月每月注射一次这两次注射中的94名中国妇女,评估了连续使用避孕注射(梅西吉纳或Cy-clofem)对凝血和纤维蛋白溶解的影响。为了提供长期使用安全性的证据,在治疗前,注射3和9后以及撤药后3个月观察到相关参数。结果如下:在注射Mesigyna的患者中,治疗过程中Ⅶ和Ⅹ的水平显着下降。 AT-Ⅲ的活性,纤溶酶原和蛋白C的浓度也降低。此外,停止治疗后相应的参数未恢复到正常水平。在治疗早期,凝血酶原时间(PT)和活化的部分凝血活酶时间(APTT)延长,但在第47周恢复正常(注射取消),其他参数未见或有轻微​​变化。在注射Cy-clofem的女性中,随着时间的流逝,因子ogen和纤溶酶原的浓度逐渐降低,而第9次注射后组织纤溶酶原激活物抑制剂(t-PAI)的水平升高,并在停药后第47周恢复正常。研究结果表明,长期使用者可以检测到一些明显的凝血和纤溶参数变化,但它们对纤溶系统的影响并不明显。所观察到的现象未显示出易于血栓栓塞的趋势以及对使用者有害的可能性。因此,观察到的变化应被视为维持凝血和纤维蛋白溶解之间平衡的反应,对使用者没有明显的临床病理意义。

著录项

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号